We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Drug-Monitoring Assays

By HospiMedica staff writers
Posted on 07 Nov 2005
New drug-monitoring assays for lithium and vancomycin are intended to insure that the level of drugs taken by patients is within therapeutic range.

The assays are designed for use on the Advia 1650, 2400, and 1200 chemistry systems of the Diagnostics Division of Bayer HealthCare (Tarrytown, NY, USA). More...
Lithium carbonate is a mood stabilizer that reduces the risk of suicide for people with biopolar disorder, once called manic depression. Characterized by extreme mood swings with episodes of severe depression, people with bipolar disorder are 10-20 times more likely to commit suicide than the general population.

Vancomycin hydrochloride is used to treat patients hospitalized for severe infections that do not respond to other antibiotics. These infections include those of the blood or bone; those of the lower respiratory tract, such as pneumonia or complications of flu; and endocarditis.

"Bayer is committed to providing a broad-enough menu to satisfy the majority of any laboratory's high volume testing needs,” said Tom Warekois, senior vice president of global strategic marketing for the Diagnostics Division of Bayer. "Combined with productive and adaptable instrumentation, Bayer Diagnostics can deliver the throughput and flexibility that laboratories and physicians need to make potentially life-saving clinical decisions faster.”

With the new assays, Bayer Diagnostics has expanded its menu offering to 78 tests on the Advia 1650 and 2400, and 62 tests on the Advia 1200.





Related Links:
Bayer Diagnostics

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.